itch targeting compound 1

Itch-Targeting Compound 1 is an anti-itch compound. It is effective in preventing or treating reactions on insect's bites, reactions on environmental allergens, skin infections, external vermination, or itches occurring in renal dialysis patients.

Antimicrobial Compound 1 is an alkyl pyridinium compound with Tail 12C, Head 4-carboxyl. Antimicrobial Compound 1 exhibits antimicrobial activities against B. subtilis and E. coli.

NPS ALX Compound 4a hydrochloride(1:1) is a potent and selective 5-hydroxytryptamine6 (5-HT6) receptor antagonist, with an IC50 of 7.2 nM and a Ki of 0.2 nM.

Antibacterial compound 1 is an antibacterial compound.

Antiasthmatic Compound 1 is an antiasthmatic agent.

Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.

VPS34 inhibitor 1 (Compound 19, PIK-III analogue) (PIK-III analogue) is a potent and selective inhibitor of VPS34( IC50 : 15 nM)

(Rac)-Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor.

Neurodegenerative Disorder-Targeting Compound 1 is an inhibitor of calpain [1].

Urinary Incontinence-Targeting Compound 1, used in the research of urinary incontinence, is a sulfonanilide derivative.

Arrhythmias-Targeting Compound 1 is a compound. It is used in the research of arrhythmias.

Asthma relating compound 1 is an anti-asthmatic compound.

Arrhythmic-Targeting Compound 1 is used for arrhythmic disease, with nitrogen-containing spirocycles.

Neuromuscular-targeting compound 1 can be used to study muscular dystrophy and neuromuscular-related diseases.

Neuromuscular Disorder-Targeting Compound 1 is a compound used in the research of neuromuscular disorders, for example, symptoms of chronic fatigue syndrome and fibromyalgia syndrome.

Compound SC-1 is a a derivative of the multiple tyrosine kinase inhibitor sorafenib. Compound SC-1 potently inhibits the phosphorylation of STAT3 by blocking STAT3 phosphorylation and activation, and induces apoptosis in hepatocellular carcinoma cell lines[1].